Medconova
Latest round
- Series A
Last raised
- Jun 2018
Total raised
- Undisclosed
Investors
- 2
About Medconova
Established in 2011 and based in Huzhou, China, Medconova operates as a medical equipment developer dedicated to providing ophthalmic diagnostic equipment. The company mainly provides visual electrophysiology detector, contact lens temperature control care device and other products. The product is suitable for diagnosis and screening of optic neuropathy, mainly glaucoma, and for evaluation and diagnosis of visual function. The product also solves the problem of low vision caused by macular degeneration.
Who invested in Medconova
2 investors across 1 round
See all investors in Medconova
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 27, 2018
Amount
Undisclosed
Investors
Questions about Medconova
Who invested in Medconova?
Medconova has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Medconova raised?
Medconova has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Medconova last raise money?
Medconova's most recent round on record is a Series A, in Jun 2018.
What does Medconova do?
Established in 2011 and based in Huzhou, China, Medconova operates as a medical equipment developer dedicated to providing ophthalmic diagnostic equipment.
Where is Medconova headquartered?
Medconova is headquartered in Huzhou, China.
Which VCs invest in companies like Medconova?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Medconova's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Medconova? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.